Compare MAGN & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MAGN | TOI |
|---|---|---|
| Founded | 1864 | 2007 |
| Country | United States | United States |
| Employees | 8500 | 641 |
| Industry | Paper | Medical/Nursing Services |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 437.2M | 512.9M |
| IPO Year | N/A | N/A |
| Metric | MAGN | TOI |
|---|---|---|
| Price | $12.69 | $5.44 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $12.00 | $6.67 |
| AVG Volume (30 Days) | 332.4K | ★ 1.9M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.37 | $30.15 |
| Revenue Next Year | $3.47 | $25.77 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.82 | $2.32 |
| 52 Week High | $15.52 | $5.82 |
| Indicator | MAGN | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 63.60 | 60.36 |
| Support Level | $9.73 | $3.24 |
| Resistance Level | $12.96 | $5.54 |
| Average True Range (ATR) | 0.59 | 0.34 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 88.48 | 63.04 |
Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.